At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09939 KINTOR PHARMA-B
Trading 12-29 14:04:33
2.030
+0.110
+5.73%
High2.110
Low1.910
Vol2.70M
Open1.910
D1 Closing1.920
Amplitude10.42%
Mkt Cap1.01B
Tradable Cap1.01B
Total Shares499.00M
T/O5.48M
T/O Rate0.54%
Tradable Shares499.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
IPO News | Haina Pharmaceutical Plans Hong Kong Listing, CSRC Requests Additional Details on Fund Usage
Two Top Analysts Reveal Career Moves: Former Guosheng Securities Pharma Chief Zhang Jinyang and Former CMSC Banking Head Wang Xianshuang Join Guolian Minsheng
AH Healthcare Assets Stage Afternoon Reversal! Medical ETF Forms Bullish Engulfing Pattern at Low, Signaling Trend Shift? Heavy "Bottom-Fishing" in HK Connect Innovative Pharma, 520880 Hits Record High
First Batch of Floating-Rate Funds Show Divergence: Yinhua Growth Smart Selection A Heavily Invested in Property and Pharma, Down 3.35% YTD, Assets Shrink 56.5%
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.